Piper Sandler Trims Celsius (NASDAQ:CELH) Target Price to $47.00

Celsius (NASDAQ:CELH) had its price objective cut by analysts at Piper Sandler from $50.00 to $47.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Piper Sandler’s price objective points to a potential upside of 43.29% from the company’s current price.

A number of other research firms also recently issued reports on CELH. UBS Group cut their target price on shares of Celsius from $70.00 to $64.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Roth Mkm cut their price objective on Celsius from $65.00 to $45.00 and set a “buy” rating for the company in a report on Thursday, September 5th. Stifel Nicolaus reduced their price objective on Celsius from $61.00 to $51.00 and set a “buy” rating for the company in a research report on Thursday, September 5th. Bank of America dropped their target price on Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research report on Thursday, September 5th. Finally, TD Cowen reduced their price target on Celsius from $68.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $57.43.

Celsius Trading Down 1.1 %

Shares of CELH stock opened at $32.80 on Tuesday. The company has a market capitalization of $7.65 billion, a price-to-earnings ratio of 36.04, a P/E/G ratio of 2.46 and a beta of 1.85. Celsius has a 1-year low of $31.55 and a 1-year high of $99.62. The stock’s fifty day simple moving average is $39.99 and its 200-day simple moving average is $63.21.

Celsius (NASDAQ:CELH) last released its earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.05. The company had revenue of $402.00 million for the quarter, compared to analysts’ expectations of $391.07 million. Celsius had a return on equity of 94.75% and a net margin of 19.58%. The business’s revenue for the quarter was up 23.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.17 EPS. On average, sell-side analysts predict that Celsius will post 0.83 EPS for the current year.

Insider Buying and Selling

In other Celsius news, CEO John Fieldly sold 74,847 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the transaction, the chief executive officer now owns 1,812,490 shares in the company, valued at $59,449,672. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Celsius

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Celsius by 183.6% during the 4th quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock worth $749,458,000 after purchasing an additional 8,899,873 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Celsius by 231.2% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock worth $225,289,000 after buying an additional 2,754,722 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Celsius by 212.2% in the fourth quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after acquiring an additional 2,306,598 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Celsius by 424.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock worth $152,287,000 after acquiring an additional 2,261,046 shares during the last quarter. Finally, Eagle Asset Management Inc. grew its stake in shares of Celsius by 188.8% in the fourth quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock worth $161,312,000 after acquiring an additional 1,934,400 shares during the last quarter. 60.95% of the stock is owned by institutional investors and hedge funds.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.